BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2396193)

  • 1. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.
    Tsuzuki T; Ueda M; Kuramochi S; Iida S; Takahashi S; Iri H
    Surgery; 1990 Sep; 108(3):495-501. PubMed ID: 2396193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group.
    Sugiura Y; Nakamura S; Iida S; Hosoda Y; Ikeuchi S; Mori S; Sugioka A; Tsuzuki T
    Surgery; 1994 Apr; 115(4):445-51. PubMed ID: 8165536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of hilar carcinoma of the bile duct.
    Mizumoto R; Kawarada Y; Suzuki H
    Surg Gynecol Obstet; 1986 Feb; 162(2):153-8. PubMed ID: 3945893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment for proximal bile duct carcinoma.
    Kusano T; Tamai O; Miyazato H; Isa T; Shiraishi M; Muto Y; Furukawa M
    Int Surg; 1998; 83(2):119-23. PubMed ID: 9851327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatectomy in the treatment of hilar bile duct carcinoma.
    Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H
    Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer?
    Veroux M; Madia C; Fiamingo P; Caglià P; Valastro M; Amodeo C; Veroux P; Gagliano M; Basso S; D'Amico DF
    J Surg Oncol; 2006 Mar; 93(3):199-205. PubMed ID: 16482599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive surgical resection for hilar cholangiocarcinoma.
    Lai EC; Lau WY
    ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections after liver resections in the elderly].
    Koperna T; Kisser M; Schulz F
    Langenbecks Arch Chir; 1997; 382(4):192-6. PubMed ID: 9445965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aggressive surgical treatment for cholangiocarcinoma].
    Shimonov M; Schecter P; Avni Y; Rabin E; Rosen A; Czerniak A
    Harefuah; 2001 Jun; 140(6):479-82, 566. PubMed ID: 11420845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases.
    Paik KY; Heo JS; Choi SH; Choi DW
    J Surg Oncol; 2008 May; 97(6):508-12. PubMed ID: 18314868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the junction of the main hepatic ducts.
    Skoog V; Thorén L
    Acta Chir Scand; 1982; 148(5):411-5. PubMed ID: 6184932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.